Translating science into breakthroughs
We conduct clinical research in the lab to understand the mechanism of disease in order to develop new diagnostics and therapeutics for patients with heart failure. Here, Dr. Fairweather examines a new biomarker for myocarditis using patient samples.
Overview
The Translational Cardiovascular Disease Research Laboratory of principal investigator DeLisa Fairweather, Ph.D., studies the identification of biomarkers that can be used as diagnostic and therapeutic targets for cardiovascular and autoimmune diseases.
Our lab, which is located at Mayo Clinic in Jacksonville, Florida, focuses on several areas of research, including:
- Discovering individualized therapies and improved diagnoses for chronic inflammatory conditions.
- Understanding how sex differences in inflammation caused by environmental exposures can lead to chronic inflammatory conditions.
- Examining the immunopathogenesis of myocarditis, dilated cardiomyopathy and heart failure.
Our goal is to develop research breakthroughs by better understanding the pathogenesis of disease characterized by sex differences. Dr. Fairweather and her research team ultimately hope to discover new diagnostic techniques and novel therapies for people with myocarditis and other cardiovascular and autoimmune diseases.